These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17242576)

  • 1. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
    Lin EC
    Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual FDG uptake of primary thyroid lymphoma after treatment may overestimate residual lymphoma.
    Fujii H; Nakadate M; Tanaka H; Harata N; Oota S; Isogai J; Yoshida K
    Ann Nucl Med; 2016 Dec; 30(10):756-759. PubMed ID: 27614754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
    Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
    Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
    Targe M; Basu S
    J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT.
    Makis W; Novales-Diaz JA; Hickeson M
    Clin Nucl Med; 2010 Jul; 35(7):517-20. PubMed ID: 20548146
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
    Makis W; Hickeson M; Novales-Diaz JA
    Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
    Salvatori M; Biondi B; Rufini V
    Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging for response assessment in lymphoma: potential and limitations.
    Schöder H; Moskowitz C
    Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
    Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
    Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
    Kuo PH; Cooper DL; Cheng DW
    Semin Nucl Med; 2006 Jan; 36(1):105-7. PubMed ID: 16356799
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET of thyroid nodules with inconclusive cytologic results.
    Martínez-Duncker C; Hurtado-López LM
    J Nucl Med; 2006 Sep; 47(9):1555; author reply 1555-6. PubMed ID: 16954566
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
    Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
    Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET for a thyroid MALT lymphoma.
    Lee CJ; Hsu CH; Tai CJ; Lin SE
    Acta Oncol; 2008; 47(6):1165-7. PubMed ID: 18770065
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of thyroid metastases from nasopharyngeal carcinoma with F-18 FDG PET/CT.
    Osmany S; Padhy AK; Ng DC
    Clin Nucl Med; 2008 Mar; 33(3):224-5. PubMed ID: 18287855
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
    Strobel K; Steinert HC; Bhure U; Koma AY; Gassmann N; Stöckli SJ
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):813. PubMed ID: 17225114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.